Active Ingredient(s): Posaconazole
FDA Approved: * September 15, 2006
Pharm Company: * SCHERING
Category: Antifungal

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Noxafil Overview

Posaconazole, sold under the brand names Noxafil and Posanol is a triazole antifungal medication.[2][3] It was approved for medical use in the United States in September 2006,[4] and is available as a generic medication.[5] Contents 1 Medical uses 2 Pharmacology 2.1 Pharmacodynamics 2.1.1 Microbiology 2.2 Pharmacokinetics 3 References 4 External links Medical uses Posaconazole is used to treat invasive Aspergillus an...

Read more Noxafil Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Noxafil Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 18mg/ml
  • Solution: 300mg/16.7ml (18mg/ml)
  • Suspension: 40mg/ml
  • Tablet, Delayed Release: 100mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Noxafil: (4 results)

Sorted by National Drug Code
  • 0085-1328 Noxafil 40 mg/ml Oral Suspension by Merck Sharp & Dohme Corp.
  • 0085-2224 Noxafil 300 mg Oral Powder, for Suspension by Merck Sharp & Dohme Corp.
  • 0085-4324 Noxafil 100 mg/1 Oral Tablet, Coated by Merck Sharp & Dohme Corp.
  • 0085-4331 Noxafil 18 mg/ml Intravenous Solution by Merck Sharp & Dohme Corp.

Other drugs which contain Posaconazole or a similar ingredient: (1 result)